BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16731643)

  • 1. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.
    Hessel MH; Steendijk P; den Adel B; Schutte CI; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2424-30. PubMed ID: 16731643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels.
    Hessel M; Steendijk P; den Adel B; Schutte C; van der Laarse A
    Cell Physiol Biochem; 2009; 24(3-4):201-10. PubMed ID: 19710535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
    Okada M; Harada T; Kikuzuki R; Yamawaki H; Hara Y
    J Pharmacol Sci; 2009 Oct; 111(2):193-200. PubMed ID: 19809219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat.
    Lamberts RR; Vaessen RJ; Westerhof N; Stienen GJ
    Basic Res Cardiol; 2007 Jan; 102(1):19-27. PubMed ID: 16944361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Benoist D; Stones R; Drinkhill M; Bernus O; White E
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2230-7. PubMed ID: 21398591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular end-diastolic stiffness heralds right ventricular failure in monocrotaline-induced pulmonary hypertension.
    Alaa M; Abdellatif M; Tavares-Silva M; Oliveira-Pinto J; Lopes L; Leite S; Leite-Moreira AF; Lourenço AP
    Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H1004-H1013. PubMed ID: 27473939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
    Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K
    Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct loading conditions reveal various patterns of right ventricular adaptation.
    Borgdorff MA; Bartelds B; Dickinson MG; Steendijk P; de Vroomen M; Berger RM
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H354-64. PubMed ID: 23729212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
    Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
    Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
    Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
    Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular performance after monocrotaline-induced pulmonary hypertension.
    Werchan PM; Summer WR; Gerdes AM; McDonough KH
    Am J Physiol; 1989 May; 256(5 Pt 2):H1328-36. PubMed ID: 2524170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
    Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A
    J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats.
    Lamberts RR; Caldenhoven E; Lansink M; Witte G; Vaessen RJ; St Cyr JA; Stienen GJ
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1869-76. PubMed ID: 17604325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
    Conzatti A; Colombo R; Siqueira R; Campos-Carraro C; Turck P; Luz de Castro A; Belló-Klein A; Sander da Rosa Araujo A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):612-620. PubMed ID: 38547510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
    Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
    Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.